← Back to Search

Behavioural Intervention

Multicomponent Telerehabilitation Intervention (Group 1) for Multi-morbidity

N/A
Recruiting
Led By Jennifer E. Stevens-Lapsley, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to 6 weeks, 12 weeks, and 24 weeks compared to the control group.
Awards & highlights

Study Summary

"This trial aims to see if a new TeleRehabilitation program can help older Veterans with complex health conditions improve their physical function better than traditional in-person rehabilitation programs."

Who is the study for?
This trial is for older Veterans with multiple chronic health conditions and physical weakness, who often feel socially isolated. They should be able to engage in high-intensity rehabilitation and self-management programs via telehealth. Specific eligibility details are not provided.Check my eligibility
What is being tested?
The study tests a Multicomponent Telerehabilitation (MCTR) program that combines motivational talks, physical therapy, health updates, consultations, and education against traditional rehab methods to see if it better improves strength and function.See study design
What are the potential side effects?
Since this trial involves non-drug interventions like interviews and physical therapy rather than medications, typical drug side effects aren't expected. However, participants may experience fatigue or discomfort from increased activity.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to 6 weeks, 12 weeks, and 24 weeks compared to the control group.
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to 6 weeks, 12 weeks, and 24 weeks compared to the control group. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
2 Minute Step Test
Secondary outcome measures
30 Second Sit To Stand
Activity Measure for Post-Acute Care (AM-PAC) basic mobility outpatient routine short form
Arm Curl Test
+11 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Multicomponent Telerehabilitation Intervention (Group 1)Experimental Treatment2 Interventions
Veterans randomized to the MCTR group will complete the 24-week study intervention consisting of the Active (weeks 1-6), Transition (weeks 7-12), and Sustainability (weeks 13-24) phases. Participants will receive a total of 16 individual sessions (6 integrated, 4 high-intensity rehabilitation, and 6 self-management intervention sessions).
Group II: Education Control (Group 2)Experimental Treatment3 Interventions
This group will not receive any exercise intervention but will complete 16 sessions with research staff through videoconferencing. These visits will consist of standardized Health Status Update and education sessions on general health topics.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Motivational Interviewing Techniques
2021
N/A
~50

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,612 Previous Clinical Trials
3,305,617 Total Patients Enrolled
5 Trials studying Multi-morbidity
953 Patients Enrolled for Multi-morbidity
Jennifer E. Stevens-Lapsley, PhDPrincipal InvestigatorRocky Mountain Regional VA Medical Center, Aurora, CO
5 Previous Clinical Trials
689 Total Patients Enrolled
1 Trials studying Multi-morbidity
50 Patients Enrolled for Multi-morbidity

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this medical trial currently accepting new participants?

"As per clinicaltrials.gov, this specific research investigation is not seeking new participants. Originally listed on April 1st, 2024, and last revised on February 23rd, 2024. While this particular trial has concluded recruitment, there are currently seventeen other trials actively seeking eligible candidates for enrollment."

Answered by AI
~84 spots leftby Nov 2026